Improving End-User Trust in the Quality of Commercial Probiotic Products
| Autor: | Christina Vegge, Buffy Stahl, Michael D. Bradley, Jean L. Schoeni, Scott A. Jackson, John B Atwater, Virginia S. Goldman, Mary Ellen Sanders, Marco Pane, Pierre Burguière |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Microbiology (medical)
Process (engineering) media_common.quotation_subject lcsh:QR1-502 third-party verification probiotic stability Review Certification Microbiology lcsh:Microbiology 03 medical and health sciences Order (exchange) Component (UML) probiotic enumeration Quality (business) Product (category theory) 030304 developmental biology media_common 0303 health sciences 030306 microbiology End user Ambiguity USP probiotics Risk analysis (engineering) quality probiotic identity standards Business |
| Zdroj: | Frontiers in Microbiology, Vol 10 (2019) Frontiers in Microbiology |
| ISSN: | 1664-302X |
| Popis: | In a rapidly growing global probiotic market, end-users have difficulty distinguishing between high quality and poor quality products. This ambiguity threatens the trust consumers and healthcare providers have in probiotic products. To address this problem, we recommend that companies undergo third-party evaluations to certify probiotic quality and label accuracy. In order to communicate about product quality to end-users, indication of certification on product labels is helpful, although not all manufacturers choose to use this approach. Herein we discuss: third-party certification, the process of setting standards for identity, purity, and quantification of probiotics; some emerging methodologies useful for quality assessment; and some technical challenges unique to managing quality of live microbial products. This review provides insights of an Expert Panel engaged in this process and aims to update the reader on relevant current scientific methodologies. Establishing validated methodologies for all aspects of quality assessment is an essential component of this process and can be facilitated by established organizations, such as United States Pharmacopeia. Emerging methodologies including whole genome sequencing and flow cytometry are poised to play important roles in these processes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|